The Patent Finder

Gene Defects and Mutant Alk Kinase in Human Solid Tumors

Cell Signaling Technology, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 9 of these applications claim priority to application 60/792,364, filed Apr 14, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,168,383Gene Defects and Mutant Alk Kinase in Human Solid Tumors
In force
 · High confidence
UsedRemaining
Cell Signaling Technology, Inc.In forceHigh confidence
US 8,288,102Gene Defects and Mutant Alk Kinase in Human Solid Tumors
In force
 · High confidence
Cell Signaling Technology, Inc.In forceHigh confidence
US 8,377,642Gene Defects and Mutant Alk Kinase in Human Solid Tumors
In force
 · High confidence
Cell Signaling Technology, Inc.In forceHigh confidence
US 9,523,130Methods of Treating Non-Small Cell Lung Carcinoma (NSCLC)
In force
 · Medium confidence
Cell Signaling Technology, Inc.In forceMedium confidence
US 9,988,688Compositions for Detecting Mutant Anaplastic Lymphoma Kinase in Lung Cancer
In force
 · High confidence
Cell Signaling Technology, Inc.In forceHigh confidence
US 10,870,892Compositions for Detecting Mutant Anaplastic Lymphoma Kinase in Lung Cancer
In force
 · High confidence
Cell Signaling Technology, Inc.In forceHigh confidence
US 10,955,416Compositions for Detecting Mutant Anaplastic Lymphoma Kinase in Human Lung Cancer
In force
 · Medium confidence
Cell Signaling Technology, Inc.In forceMedium confidence
US 11,505,833Compositions for Detecting Mutant Anaplastic Lymphoma Kinase in Lung Cancer
In force
 · High confidence
Cell Signaling Technology, Inc.In forceHigh confidence
US 7,700,339Gene Defects and Mutant Alk Kinase in Human Solid Tumors
In force
 · High confidence
Cell Signaling Technology, Inc.In forceHigh confidence
Application 13/940,521Gene Defects And Mutant ALK Kinase In Human Solid Tumors
Abandoned
Abandoned Jul 21, 2017
Cell Signaling Technology, Inc.AbandonedAbandoned Jul 21, 2017
1 more record in this group · Pro
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11, including 9 expiring within the 18 months from Nov 20, 2026.
Upgrade to Pro
9 of these are in force and held by Cell Signaling Technology, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited